255 related articles for article (PubMed ID: 23860082)
21. Nuclear factor-κB activation inhibitor attenuates ischemia reperfusion injury and inhibits Hmgb1 expression.
Shi Z; Lian A; Zhang F
Inflamm Res; 2014 Nov; 63(11):919-25. PubMed ID: 25209109
[TBL] [Abstract][Full Text] [Related]
22. Role of T-cell-specific nuclear factor κB in islet allograft rejection.
Porras DL; Wang Y; Zhou P; Molinero LL; Alegre ML
Transplantation; 2012 May; 93(10):976-82. PubMed ID: 22437847
[TBL] [Abstract][Full Text] [Related]
23. Antitumor effect of a novel nuclear factor-kappa B activation inhibitor in bladder cancer cells.
Horiguchi Y; Kuroda K; Nakashima J; Murai M; Umezawa K
Expert Rev Anticancer Ther; 2003 Dec; 3(6):793-8. PubMed ID: 14686701
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of macrophage activation and phagocytosis by a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Suzuki E; Umezawa K
Biomed Pharmacother; 2006 Nov; 60(9):578-86. PubMed ID: 16978829
[TBL] [Abstract][Full Text] [Related]
25. Potent cytotoxic effect of a novel nuclear factor-kappaB inhibitor dehydroxymethylepoxyquinomicin on human bladder cancer cells producing various cytokines.
Kodaira K; Kikuchi E; Kosugi M; Horiguchi Y; Matsumoto K; Kanai K; Suzuki E; Miyajima A; Nakagawa K; Tachibana M; Umezawa K; Oya M
Urology; 2010 Apr; 75(4):805-12. PubMed ID: 20156648
[TBL] [Abstract][Full Text] [Related]
26. Amelioration of experimental autoimmune uveoretinitis with nuclear factor-{kappa}B Inhibitor dehydroxy methyl epoxyquinomicin in mice.
Iwata D; Kitaichi N; Miyazaki A; Iwabuchi K; Yoshida K; Namba K; Ozaki M; Ohno S; Umezawa K; Yamashita K; Todo S; Ishida S; Onoé K
Invest Ophthalmol Vis Sci; 2010 Apr; 51(4):2077-84. PubMed ID: 19907030
[TBL] [Abstract][Full Text] [Related]
27. Dehydroxymethylepoxyquinomicin (DHMEQ), a novel NF-kappaB inhibitor, inhibits allergic inflammation and airway remodelling in murine models of asthma.
Shimizu K; Konno S; Ozaki M; Umezawa K; Yamashita K; Todo S; Nishimura M
Clin Exp Allergy; 2012 Aug; 42(8):1273-81. PubMed ID: 22805475
[TBL] [Abstract][Full Text] [Related]
28. Effects of a novel NF-kappaB inhibitor, dehydroxymethylepoxyquinomicin (DHMEQ), on growth, apoptosis, gene expression, and chemosensitivity in head and neck squamous cell carcinoma cell lines.
Ruan HY; Masuda M; Ito A; Umezawa K; Nakashima T; Yasumatsu R; Kuratomi Y; Yamamoto T; Weinstein IB; Komune S
Head Neck; 2006 Feb; 28(2):158-65. PubMed ID: 16355386
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of inflammatory mediator secretion by (-)-DHMEQ in mouse bone marrow-derived macrophages.
Suzuki E; Sugiyama C; Umezawa K
Biomed Pharmacother; 2009 Jun; 63(5):351-8. PubMed ID: 18635336
[TBL] [Abstract][Full Text] [Related]
30. Dendritic cells conditioned with NK026680 prolong cardiac allograft survival in mice.
Shibasaki S; Yamashita K; Yanagawa Y; Goto R; Wakayama K; Hirokata G; Tsunetoshi Y; Zaitsu M; Igarashi R; Haga S; Ozaki M; Todo S
Transplantation; 2012 Jun; 93(12):1229-37. PubMed ID: 22643332
[TBL] [Abstract][Full Text] [Related]
31. Inhibition of inflammatory cytokine secretion from mouse microglia cells by DHMEQ, an NF-kappaB inhibitor.
Takatsuna H; Morita S; Nagatsu T; Sawada M; Umezawa K
Biomed Pharmacother; 2005 Jul; 59(6):318-22. PubMed ID: 15932789
[TBL] [Abstract][Full Text] [Related]
32. A major role for host MHC class I antigen presentation for promoting islet allograft survival.
Beilke J; Johnson Z; Kuhl N; Gill RG
Transplant Proc; 2004 May; 36(4):1173-4. PubMed ID: 15194406
[TBL] [Abstract][Full Text] [Related]
33. A novel nuclear factor κB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice.
Shimo T; Adachi Y; Yamanouchi S; Tsuji S; Kimata T; Umezawa K; Okigaki M; Takaya J; Ikehara S; Kaneko K
Am J Nephrol; 2013; 37(4):302-9. PubMed ID: 23548793
[TBL] [Abstract][Full Text] [Related]
34. Dehydroxymethylepoxyquinomicin (DHMEQ) therapy reduces tumor formation in mice inoculated with tax-deficient adult T-cell leukemia-derived cell lines.
Ohsugi T; Kumasaka T; Okada S; Ishida T; Yamaguchi K; Horie R; Watanabe T; Umezawa K
Cancer Lett; 2007 Nov; 257(2):206-15. PubMed ID: 17764832
[TBL] [Abstract][Full Text] [Related]
35. Induction of thyroid cancer cell apoptosis by a novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin.
Starenki DV; Namba H; Saenko VA; Ohtsuru A; Maeda S; Umezawa K; Yamashita S
Clin Cancer Res; 2004 Oct; 10(20):6821-9. PubMed ID: 15501958
[TBL] [Abstract][Full Text] [Related]
36. A more persistent tolerance to islet allografts through bone marrow transplantation in minimal nonmyeloablative conditioning therapy.
Lee BW; Lee JI; Oh SH; Ahn YR; Chae HY; Lee MS; Lee MK; Kim KW
Transplant Proc; 2005 Jun; 37(5):2266-9. PubMed ID: 15964395
[TBL] [Abstract][Full Text] [Related]
37. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
38. Human islets express a marked proinflammatory molecular signature prior to transplantation.
Cowley MJ; Weinberg A; Zammit NW; Walters SN; Hawthorne WJ; Loudovaris T; Thomas H; Kay T; Gunton JE; Alexander SI; Kaplan W; Chapman J; O'Connell PJ; Grey ST
Cell Transplant; 2012; 21(9):2063-78. PubMed ID: 22404979
[TBL] [Abstract][Full Text] [Related]
39. Antitumor effects of dehydroxymethylepoxyquinomicin, a novel nuclear factor-kappaB inhibitor, in human liver cancer cells are mediated through a reactive oxygen species-dependent mechanism.
Lampiasi N; Azzolina A; D'Alessandro N; Umezawa K; McCubrey JA; Montalto G; Cervello M
Mol Pharmacol; 2009 Aug; 76(2):290-300. PubMed ID: 19461054
[TBL] [Abstract][Full Text] [Related]
40. Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.
Kuroda K; Horiguchi Y; Nakashima J; Kikuchi E; Kanao K; Miyajima A; Ohigashi T; Umezawa K; Murai M
Clin Cancer Res; 2005 Aug; 11(15):5590-4. PubMed ID: 16061877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
